China's Bio-Thera gets approval for Humira biosimilar

China's Bio-Thera Solutions Ltd has won a regulatory approval for its version of AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, paving the way for the first such biosimilar to enter the world's second-largest drug market.

from Reuters: Health News https://ift.tt/32kZqAZ